From Inside Health Policy July 22, 2013 Proposed Rule, Guidance Lay Out FDA Enforcement On Drug Supply Chain

FDA is taking steps to institute a drug supply chain enforcement plan under which the agency would detain drugs it believes are adulterated as well as penalize manufacturers that do not comply with agency inspectors, issuing a proposed rule and draft guidance July 12 . . .

subscription required